These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11466622)

  • 1. Radiation induces genomic instability and mammary ductal dysplasia in Atm heterozygous mice.
    Weil MM; Kittrell FS; Yu Y; McCarthy M; Zabriskie RC; Ullrich RL
    Oncogene; 2001 Jul; 20(32):4409-11. PubMed ID: 11466622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
    Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
    Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.
    Mandriota SJ; Buser R; Lesne L; Stouder C; Favaudon V; Maechler P; Béna F; Clément V; Rüegg C; Montesano R; Sappino AP
    J Biol Chem; 2010 Apr; 285(17):13092-106. PubMed ID: 20177072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
    Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
    Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
    Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
    Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
    Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
    Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygosity for a mutation in Brca1 or Atm does not increase susceptibility to ENU-induced mammary tumors in Apc(Min)/+ mice.
    Karabinis ME; Larson D; Barlow C; Wynshaw-Boris A; Moser AR
    Carcinogenesis; 2001 Feb; 22(2):343-6. PubMed ID: 11181458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of cell cycle regulator ATM, Chk2 and p53 and their clinicopathological correlation in breast infiltrative ductal carcinoma].
    Pei XJ; Yang QX; Liu SJ; Su M; Huang ZY; Han AJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):479-80. PubMed ID: 22932461
    [No Abstract]   [Full Text] [Related]  

  • 10. ATM protein synthesis patterns in sporadic breast cancer.
    Kairouz R; Clarke RA; Marr PJ; Watters D; Lavin MF; Kearsley JH; Lee CS
    Mol Pathol; 1999 Oct; 52(5):252-6. PubMed ID: 10748873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity.
    Wang J; Su F; Smilenov LB; Zhou L; Hu W; Ding N; Zhou G
    Radiat Oncol; 2011 Aug; 6():96. PubMed ID: 21849032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
    Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
    Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
    Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
    J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines.
    Kovalev S; Mateen A; Zaika AI; O'Hea BJ; Moll UM
    Int J Oncol; 2000 Apr; 16(4):825-31. PubMed ID: 10717253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATM gene and breast cancer: is it really a risk factor?
    Angèle S; Hall J
    Mutat Res; 2000 Apr; 462(2-3):167-78. PubMed ID: 10767628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
    Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
    Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.
    Arlander SJ; Greene BT; Innes CL; Paules RS
    Cancer Res; 2008 Jan; 68(1):89-97. PubMed ID: 18172300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
    Iannuzzi CM; Atencio DP; Green S; Stock RG; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):606-13. PubMed ID: 11849780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced radiation-mediated cell killing of human cervical cancer cells by small interference RNA silencing of ataxia telangiectasia-mutated protein.
    Li W; Jian W; Xiaoping X; Yingfeng L; Tao X; Xiaoyan X
    Int J Gynecol Cancer; 2006; 16(4):1620-30. PubMed ID: 16884376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.